Abbott’s Compounding Pharmacy Recalls Products
Abbott’s Compounding Pharmacy voluntarily recalls sterile products due to lack of sterility assurance.
On Jan. 16, 2016, Abbott’s Compounding Pharmacy announced it was voluntarily recalling all unexpired lots of human and animal sterile compounded products including injectable medications, sterile solutions, eye drops, and eye ointments. The recall is in response to a concern of a lack of sterility assurance after a series of onsite FDA inspections. The recalled products were distributed in California.
The recall is cautionary and the company has not received any reports of adverse events regarding the recalled products as of Jan. 16, 2016. However, because microbial contamination could cause serious effects, the company is advising customers to stop using the products immediately and contact their healthcare provider if they experience problems related to the use of the products.
Source: FDA
Novo Nordisk Hemophilia Treatment Gets Positive Opinion from CHMP
October 23rd 2024As many as 30% of people living with severe hemophilia A develop inhibitors such as TFPI, which can be produced by the body’s immune response to clotting factors in replacement therapy, often limiting the effectiveness of that therapy.
